Open AccessLong-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial
Author(s) -
C.J. Tack,
S. Jacob,
C. Desouza,
S.C. Bain,
J.B. Buse,
M.A. Nauck,
J.R. Petrie,
N.R. Poulter,
R.E. Pratley,
H.V.B.K. Stegmann,
H. Bosch-Traberg,
E. Startseva,
B. Zinman,
The LEADER Publication Committee on behalf of the LEADER Trial Investigators
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/d1hv-pw35
Subject(s) - term (time) , insulin , glucagon like peptide 1 , medicine , endocrinology , diabetes mellitus , type 2 diabetes , physics , quantum mechanics